Facing high water, Hudson towns reimagine waterfronts

With the Hudson River rising from a fast-warming climate, the cities and towns along its banks now have an opportunity to save and reimagine their municipal waterfronts.

Migrations project helps refugees claim health care rights

A Cornell collaboration crossing medicine, law, technology and communication is aiming to encourage the use of health care benefits by refugees in the U.S. – who often suffer poor health but are using these entitlements less than they have in the past.

Pandemic prompted exodus from New York City, gains upstate

An analysis of newly released census data by the Cornell Program on Applied Demographics shows how the pandemic’s onset influenced populations in each New York state county.

Study reveals structure of anti-tumor therapy’s target

Using cutting-edge techniques, researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have visualized the structure of a receptor targeted by an anti-cancer immunotherapy. The finding may help scientists improve this type of cancer treatment.

How YouTube can fix its demonetization strategy

New research shows that if YouTube wants to truly impact channels that distribute problematic content, it should develop a shared database of demonetized users with Patreon and Twitch to prevent them from using each other’s platforms.

‘Earth is transitioning’: Models suggest more megadroughts

By the end of this century, Cornell’s Flavio Lehner and others said that megadroughts – extended drought events that can last two decades – will be more severe and longer in the western U.S. than they are today.

Students celebrate Match Day at Weill Cornell Medicine

Students in the Weill Cornell Medical College Class of 2022 learned on national Match Day where they will be doing their internship and residency training – setting the stage for the next several years of their medical careers and lives.

Toxin-producing yeast strains in gut fuel IBD

Individual Candida albicans yeast strains in the human gut are as different from each other as the humans that carry them, and some C. albicans strains may damage the gut of patients with inflammatory bowel disease, according to a new study from researchers at Weill Cornell Medicine.

Enzyme could be new target for cancer immunotherapies

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert Einstein College of Medicine.